Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries

Keyphrases

• Angiotensin Receptor Blockers 100%
• Antagonistic Effect 100%
• Angiotensin II (Ang II) 100%
• Human Coronary Artery 100%
• Receptor Antagonist 40%
• 2 Receptor 40%
• Losartan 30%
• Angiotensin II Type 1 Receptor (AT1R) 30%
• AT-1 30%
• EXP3174 30%
• Quantitative PCR 20%
• Candesartan 20%
• Active Metabolite 20%
• Vasodilator 20%
• Valsartan 20%
• MRNA Expression 10%
• Clinical Practice 10%
• AIMS™ 10%
• Hypertension Management 10%
• Inhibitory Effect 10%
• Congestive Heart Failure 10%
• Vasoconstriction 10%
• Endothelium 10%
• Vasomotor Tone 10%
• Maximal Voluntary Contraction 10%
• Emax 10%
• Cardiovascular Pathophysiology 10%
• PD123319 10%
• Angiotensin II Type 1 10%
• Blocking Effect 10%
• Ang II Receptor Blockers 10%
• Coronary Artery Segment 10%
• HCASMC 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin Receptor Antagonist 100%
• Angiotensin II 100%
• Receptor Antagonist 44%
• Losartan 33%
• Receptor 22%
• Candesartan 22%
• Active Metabolite 22%
• Valsartan 22%
• RNA Directed DNA Polymerase 22%
• Pathophysiology 11%
• Congestive Heart Failure 11%
• Receptor Blocking Agent 11%